Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 1Gaucher Disease 1

Interventions

ganglioside, GD2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gaucher Disease × ganglioside, GD2 × Clear all
NCT04637503 2020-11-19

4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

Shenzhen Geno-Immune Medical Institute

Phase 1/2 Unknown
100 enrolled
CNS

Gaucher Disease, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡